0

0

0

0

0

0

0

0

0

videos | IST

COVID-19: Hopefully we should have a vaccine ready by the year-end, says AIIMS Director Randeep Guleria

Total confirmed COVID-19 infections in India moved closer to 44 lakh after nearly 90,000 cases were reported in the last 24 hours. Active cases now stand at almost 9 lakh. A record of nearly 75,000 people recovered on September 8, taking total recoveries closer to 34 lakh. For the eighth straight day, India reported over 1,000 deaths taking the overall tally close to 74,000.
With over 2 lakh confirmed infections, Pune has overtaken Delhi as the worst-affected city. Pune also has the most active cases in the country at the moment. Bengaluru is just below Mumbai and above Thane with over 1.5 lakh confirmed cases.
As for the hunt for a COVID-19 vaccine -- the phase three trial of the Oxford AstraZeneca COVID vaccine candidate has been paused in the UK -- trials have been halted over a "potentially unexplained illness", pending a review. This comes days after AstraZeneca along with eight other pharma giants took a pledge to uphold scientific and ethical standards in the search for a vaccine.
Serum Institute, the Indian partner for the Oxford AstraZeneca vaccine candidate, however told CNBC-TV18 that trials in India haven't been halted.
Meanwhile, a study by ICMR, the Centre's apex medical body has found that plasma therapy for COVID-19 has no benefit either in reducing mortality or arresting the progression of the virus. To discuss this, Shereen Bhan spoke to Dr Randeep Guleria, Director of AIIMS New Delhi and Dr Hemant Deshmukh Dean of KEM Hospital.
Watch the video for more.